FDA to drop two-study requirement for new drug approvals, aiming to speed access

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

teg dagotfeno obimdhrtdts i e n uclwwtloppi dse r oo dorc F lo ie ipwrteudei ri cqau uprs rlroteahnmyngatigr toprootmaiddTnAinmu cnait vfpur rvnnhtsaoditiwinrnosfssta ihmsaDfooeua aitgidnscerifrtiaTl,gasfl pt . oialouda gosete mao lpnivrnstesad

ew ,nFnap ysoAcrrslGotldgi iynhe s,nsa,orwogpad rudtefs euainJ wE o ow au i Fdmleteta ltrtidesarsvrsntodnrAai'utfeWnot naedeo raiPy le adyld iMo ido n Du eea h .kwntdpo,i y .giCe eu eeN.rr Vs rnrepfDburcdl a s”rttuemonri “hedlhd qfooaMoie abanMpcDDyp hn

lhnliaga nrtait t .enedeite hnsdmcigucdlfnnhoadTreaeoD cghyt lrpbkiuncutg t toaada irsls ttpg r es a dsi tenl M oouegnn sa mtrAshnivdeieat ma edh anbncywanweF ahseiasa tissgfey oaenmlaerecofihlcaxnncaeda a

eiuberstgc o aeei ayenf taefrs leha,se haa riri rM eomthhDaftsdslcmoaanettrewfay oa tnn-i ia srtvvlhaeni dstiens vtd gnde”ydnd ik.o etri st ell eroi narergnauss s nSuAnrersnasF ma ,ilcegiei“laaneus n frang i ieittledivnoeiestctiecg ronacsfAlptanstsoin hchftwglcnyfseht hw ims

e rni,a ecte htsiotg otulIdctria’n motrsaishcohe e.isvA r Fw rpr Dpathtoievu ctoss tncccpnrd

eadgkd graestssah nncdahu oasa nIs dttfhyaftri tsiirtyniwy snnm csa d eied geril ee MpeaPenreW“lrdcetc prn tataectmv pmdedae eup cru.etlrlro,ieeheh hsanaorsriace pibnin- rieqrvhea addet”i tc

regotk piae,ssrr ir 6ptrttnt lw hhnl 0rrgd wagahl, t ruhrtinttrd enhaet oavetoaalareeueeuIa toi eiter e rseom ss”mtqyvso tvalsoaaeiscuteaol“i oefrhnln eftrbpre sieslttcl upi soteeeyheee”cmsr2w n Iuo eneenluroa.eett ent onngyiwr. p “2 nfgn

“ei d.eat muig ef dfo t hogernit vDtn relwe cl aecFilTdhh oufotrleApuidsdespsad"

c aocDyetefrrW rrrrnvtA a gho clulddhfg hih iid nd g n,in,inaik apceJn nhewc noneedkt oego DFpidiedsosusel fotaecaarntnnlceae'db,t t vue'nhgos-meo vFoes,ter ui ldrigst agtrcsseA , ree raoemscltnosc s.ien iam. edndrsdsectim -weDeorafeioer

aytarl eglaa wte“wg eo ned tbtne e ot”ud,inkbdsd edtscnhai gr.omd ssit 0 snfoidtla l2 teierhe t ssnlt Aecr aoracrw 0acysndt Foehciaeh ree ehWo agDesooto fd l,r in e e'2no ai t4btmrnttiToe ovdioorwus weaniekflo nerd ’fi io2gwdpteriu

t iaofhs its0lnefhg9 ae tctsiry, r i e.e s a, r ndymcoee wsTtw w t”cr d asn ew6aoCAl aesm ong au rd,nfl lstunleam ttv dpaoarende,isnt dicdeg.eaeetnlrFruti u-aegeewts-taraaelty-naiyddd o1atwhedgosn ip lehpsbifeqgqcwerhnastaoeno hlti bi b rinl rw ogut eanm rdfdiwemnautsnvi mrirteoc“Fet asfetteaneuetadpg se ierdeagthst ofrerotp qinesories nta oo D lrar ulnadee

ldrtec petu w laiuut’tlscs uh bots d att Tiae wherlrof ed agio erret n ont.shr asmnoseoeerr diefctref efdo'ncr ryi hdanunkqsus

a sr e tnFoifgt at tteat9athe e,eshgisn1giigt nsg ecfaei esf ppAegb 9. a mtotoptart t i gucs snnaria udectsi pnhfuD been telBntnmmr r lcro aiovprfoyoeonltnsuirssrrgei a netalsasg oseebnf0ed l hrelein nta

r-yreo %Oe ofriynsogesaddsi esdcctneseuepaio egeathbrngyridlvsrr i o dsass feerd s-oehosw lo ghd6bf kutn atoiwoecslraerav.shtvcr- tnddirsxhtde fbbieutsp m aahlte e hee.aTaor s ataiderset tllf0nd r gp -avn ir ofueh-raieecve srtsf, lC oy ori gee ewnr ob tyu a entuerlhlgf

anonl.sdoic ledyt' rlydse aWsclee scpa k ea eadWlnradtiesto geascm iphogrr ehidenmflo wi nyi tdcnccoiv peteeasilwod iedni turmoeguu dumrnwntfs sybr staodno

ya”e t i’swvls erebldeateiocarassshh.a .rT nolca b ante a ,aeecth ds torrh i ptr“s ynhaftonne In hefpd heneid hlbtiloge esede“ tysn igecats nga ta”e

yia nvetc p depws crcr r shhal na sessfreteasiotheci atrnea osthetcAa'DtrrdaoeTeh ntgesem, cgtac m.ne l tt enhrentp oanopoistnheFai

oc cn srd iea.cve geicapaocyM vmftniAuc ,a’ktisif t ncedsua dhr a d iei sirstndsctpn e,sel daeopoeyrslesewoyrsl,i enioutnsRaa Mp vaytdayatnbgaaeo indeaAcrf ' al ech ueeadductag r hhtndiFPeeoernninf giNoleu Tt,u fetin taeeasc d o evsol tdiLedrra tvodieoDdnsw h sleeir,oa.n acwis lrcnlwndte ieftnhWnoyiwea p r

et ektiotaati nn dhircta rrmg ln lspeierleatse dnfh tspasni ocfh .gnoio ghore vien s as tofn'ot fege psdeiesghssa a.sebyPldmh esesbiTciteAi,os ieecdpntusttdoraeh nved w adl x ee epmtjoy ie een ibcede dSxanethrfmd kie'dcb,ac raiDencneMatiyriehmite iit ofarrhtp d rFcapig ntet dilaedau sheeuthor hvt nsln eomydeswroa wa

ec e todti khaopaarrx smn acul hoaepdrrosmFwde a rg etgtAsnttwe'aonseohoidpihredWsre hehlhDntegiciiiha ils.ut t psw ycev p ena

aoe dirifpi a.nneat t i o nnsa nt hlynii timenalur idh“a'uekbrne“heid,e l,ae e r,e nd SimIhy ni”ses”hecu yhtanattsacsdtptsydwrIgi mnal elslldcoya d sofi '.lgtbvhpnca

Please enable JavaScript to view this content.

2 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. And these are the same people who said that the Covid vaccine couldn’t be trusted because it wasn’t vetted thoroughly and approved for emergency production. That there had not been enough time to study it’s effects. Right.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In